DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
— - 2 Elon Musk - 2 Jared Holz Jared Holz - 1 Robert F - 1 Kennedy Jr - 1 Kennedy - 1 Nicole Shanahan - 1 Sergey Brin - 1
Top related locs:
Mizuho U.S Asia Asia Pacific Australia GLP WuXi China
Top related orgs:
Mizuho Securities - 1 Service - 1 The New York Times - 1 Times - 1 Business - 1 RFK - 1 PAC - 1 People Magazine - 1

Search resuls for: "Health Care Equity"


4 mentions found


☆ Medicare's drug pricing can give investors certainty on healthcare stocks, says Mizuho's Jared Holz
  + stars: | 2024-07-25 | by ( ) www.cnbc.com   time to read: 1 min
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailMedicare's drug pricing can give investors certainty on healthcare stocks, says Mizuho's Jared HolzJared Holz, Mizuho Securities health care equity strategist, joins 'Power Lunch' to discuss healthcare stocks, where he sees the sector heading, and more.
Persons: Jared Holz Jared Holz Organizations: Mizuho Securities Locations: Mizuho
☆ Sergey Brin's ex-wife was the primary funder of an RFK Jr.-supporting Super Bowl ad panned by some in the Kennedy family
  + stars: | 2024-02-14 | by ( Hannah Getahun | ) www.businessinsider.com   time to read: +4 min
Read previewThe Robert F. Kennedy Jr. -supporting Super Bowl ad that shook up the Kennedy family was backed by a tech-connected figure. This story is available exclusively to Business Insider subscribers. Advertisement"She's a very strong supporter of Robert F. Kennedy Jr.," Tony Lyons, a co-chairman of American Values 2024, told Business Insider on Tuesday. Kennedy, as Business Insider has previously reported, has made numerous false claims about vaccines and vaccine safety. Shanahan played a part in putting together the archival footage for the Kennedy ad.
Persons: —, Robert F, Kennedy Jr, Kennedy, Nicole Shanahan, Sergey Brin, ” Shanahan, John F, Tony Lyons, Bobby Kennedy, Shanahan, Bobby Shriver, Kennedy’s, Lyons, husband Brin, Elon Musk, Brin, Musk, Neuralink Organizations: Service, The New York Times, Times, Business, RFK, PAC, People Magazine
☆ Want to cash in on the weight-loss drug boom? Morgan Stanley names 4 global stocks
  + stars: | 2024-02-01 | by ( Amala Balakrishner | ) www.cnbc.com   time to read: +4 min
Under-the-radar stock picks Morgan Stanley reckons the way to play the obesity theme in Asia is through names involved in GLP-1 drug development that "could find upside in burgeoning overseas markets." Calling it "top beneficiary as global demand for GLP-1 drugs significantly outpaces capacity," Morgan Stanley has an overweight rating on the stock. Morgan Stanley has an investment horizon of just over six months for WuXi AppTec and Innovent and over 12 months for Chugai and EBOS. Morgan Stanley's analysts estimate that worldwide sales of Orforglipron could hit $7 billion in 2023. Elsewhere, it sees opportunities for EBOS following the Australian government's approval for it to distribute obesity drugs.
Persons: Eli Lilly, Morgan, Sean Wu, Morgan Stanley's, Health Organization's, Morgan Stanley, Chugai, Goldman, EBOS, CNBC's Michael Bloom Organizations: Novo Nordisk, Health, WHO, BMI, WuXi AppTec, Australian, Hong Kong Stock Exchange, China Health Care, Goldman Sachs, Health Care Equity, Zealand ETF Locations: U.S, Asia, Asia Pacific, Australia, GLP, WuXi, China, Japan, New Zealand, Zealand
☆ Can you hack your brain? These companies are driving innovation in the field of brain stimulation
  + stars: | 2023-11-21 | by ( Pia Singh | ) www.cnbc.com   time to read: +12 min
These forms of deep brain stimulation require a surgical procedure during which electrodes — which generate electrical impulses to control any abnormal brain activity — are implanted into certain areas of the brain. With enough advancement in the field, doctors expect brain stimulation techniques for both severe disorders and health-and-wellness purposes will ultimately become noninvasive. Three major players There are only three companies with FDA-approved deep brain stimulation, or DBS, treatments: Medtronic , Abbott Laboratories and Boston Scientific . The spinal cord stimulation, or SCS, business is a hotbed of innovation right now, deep brain stimulation also is a key area." There is still plenty of doubt, however, about the efficacy of at-home brain stimulation devices, which offer a less direct approach to brain stimulation and don't always require FDA oversight.
Persons: —, Bernstein, Lee Hambright, Hambright, Ali Rezai, Medtronic, Abbott, Rezai, Morningstar, Debbie Wang, Wang, Elon Musk, it's Elon Musk's, Casey Halpern, it's, Halpern, Taiwan's Organizations: Drug Administration, FDA, Abbott Laboratories, Boston, Rockefeller Neuroscience, West Virginia University, American Neuromodulation Society, Boston Scientific, DBS, FactSet, Neuroscience, BCI, University of Pennsylvania, TMS Locations: neuromodulation
0 next >>
Total: 4